Substituted 6-cycloamino-3-(pyridazin-4-yl)imidazol[1,2-b)-pyridazine compound

Abstract

The invention relates to a compound of the general formula (I) in which R2 represents an optionally substituted aryl group; A represents an optionally substituted group C1-7-alkylene; B represents an optionally substituted group C1-7-alkylene; L represents either a nitrogen atom optionally substituted with a group Rc or Rd, or a carbon atom substituted with a group Re1 and a group Rd or two groups Re2; the carbon atoms of A and of B being optionally substituted with one or more groups Rf, which may be identical to or different from each other; R7 and R8 represent, independently of each other, a hydrogen atom or a group C1-6-alkyl, process for the preparation thereof, and pharmaceutical composition containing it.